We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
신규 편입 · 포트폴리오 비중 0.02%
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $3.72 · 5 analysts
Stored first · Google News · Yahoo Finance (English)
What Lexicon Pharmaceuticals (LXRX)'s Broad Russell Index Inclusion Means For Shareholders - simplywall.st
What Lexicon Pharmaceuticals (LXRX)'s Broad Russell Index Inclusion Means For Shareholders simplywall.st
Lexicon Pharmaceuticals (LXRX) Short Interest & Short Float | Updated Jul 2026 $LXRX - MarketBeat
Lexicon Pharmaceuticals (LXRX) Short Interest & Short Float | Updated Jul 2026 $LXRX MarketBeat
Lexicon Pharmaceuticals outlines its path in gastrointestinal disease. Drug pipeline and Nasdaq list - ad-hoc-news.de
Lexicon Pharmaceuticals outlines its path in gastrointestinal disease. Drug pipeline and Nasdaq list ad-hoc-news.de
Lexicon Pharmaceuticals highlights diabetes drug focus. Strategy matters more than near-term headlin - ad-hoc-news.de
Lexicon Pharmaceuticals highlights diabetes drug focus. Strategy matters more than near-term headlin ad-hoc-news.de
LXRX News | LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) - ChartMill
LXRX News | LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) ChartMill
If You Invested $1,000 in Lexicon Pharmaceuticals Inc (LXRX) - Stock Titan
If You Invested $1,000 in Lexicon Pharmaceuticals Inc (LXRX) Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | After market close (AMC) | $-0.05 | — | — | $4M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.07 | — | — | $1.26M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.54 | — | — | $4.53M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.37 | — | — | $2.78M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 12. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 03. 24. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 10. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 03. 06. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 09. 03. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 08. 08. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 7,814,606 | $12.19M | 0.02% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 1,199,632 | $1.87M | 0.00% | — | New position |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 637,308 | $732.9K | 0.00% | — | New position |
| 4 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 284,025 | $326.63K | 0.00% | — | New position |